Results 151 to 160 of about 31,024 (202)

Porokeratosis ptychotropica mimicking a herpes simplex virus infection. [PDF]

JAAD Case Rep
Pomerantz ER, Rhein JG, Lee JB, Hsu S.
europepmc   +1 more source

Clinical Trial Designs for Rare Disorders: A Scoping Review of the Effectiveness of Pharmacologic Interventions in Fragile X Syndrome. [PDF]

Neurol Genet
Van Steenbergen A, Kaur M, Rubanarayana K, Bolduc F.   +3 more
europepmc   +1 more source

Development and Application of an Algorithm for Statin-Induced Myopathy Based on Electronic Health Record-Derived Structured Elements. [PDF]

Pharmacoepidemiol Drug Saf
Oni-Orisan A, Lu M, Peng JA, Krauss RM, Iribarren C, Medina MW.   +5 more
europepmc   +1 more source

Siglec6 CAR T cells suppressed progression of AML via inhibiting Siglec6 and SHP2 induced Src and ERK signaling activation. [PDF]

Sci Rep
Li Q, Lin L, Gao S, Chen L, Zhang Z, Ma J, Liu S, Cao Z, Zhao H, Wang Y.   +9 more
europepmc   +1 more source

Integrated metabolomics and network pharmacology to investigate the anti-hyperlipidemia effect of geniposidic acid on high-fat diet induced mice. [PDF]

Front Cell Dev Biol
Tang R, Li K, Liang M, Wang P, Li Z.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Lovastatin

Archives of Internal Medicine, 1990
Two patients who developed hypoprothrombinemia and bleeding due to lovastatin-warfarin drug interaction are described. Because of the wider use of lovastatin and warfarin, heightened clinical awareness of this potentially serious interaction must be publicized.
  +5 more sources

Lovastatin

Reactions Weekly, 1994
  +6 more sources

Lovastatin

Reactions, 1989
A. W. Alberts, J. S. MacDonald, A. E. Till, J. A. Tobert   +3 more
  +5 more sources